ALEXANDRIA, Va. (April 16, 2025) – President Donald Trump on Tuesday signed an executive order that aims to lower drug prices and includes provisions to reevaluate the role of middlemen in the supply chain and improve transparency into pharmacy benefit managers. The National Community Pharmacists Association issued the following statement reacting to the order:
“While the devil will be in the details and in the implementation, we are optimistic that the administration is making moves to address PBMs. President Trump has talked several times about the need to rein them in, and we’re pleased he’s looking to do so. Independent community pharmacies are competing against a deck that is stacked against them by PBMs who want to stomp out their competition through anticompetitive tactics like paying the pharmacy below its cost to buy drugs and overzealous audits. Ultimately these henchmen for Big Insurance increase prescription costs and reduce access for consumers. For these pharmacies and the millions of patients who rely on them, the quicker PBMs can be brought to heel, the better, whether through executive orders, regulation, PBM reform legislation, or a combination of actions.”
To read the executive order, click here.
To read a fact sheet about the president’s action, click here.
###
Founded in 1898, the National Community Pharmacists Association is the voice for the community pharmacist, representing over 18,900 pharmacies that employ more than 205,000 individuals nationwide. Community pharmacies are rooted in the communities where they are located and are among America’s most accessible health care providers. To learn more, visit www.ncpa.org.
